Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|February 21, 2012
Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cellsJoanna Jagielska, Piyushkumar R Kapopara, Gustavo Salguero, et al.
Blood|January 9, 2010
Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regenerationKarsten Grote, Harald Schuett, Gustavo Salguero, et al.
International Journal of Molecular Sciences|April 14, 2026
Transient miR-92a Induction in Intermediate Monocytes (CD14++CD16+) in Acute Coronary Syndrome (ACS)Lukas Harbaum, Julian Kreutz, Carina Weibler, et al.
Atherosclerosis|August 24, 2005
Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosisChristina Grothusen, Sylvia Bley, Tina Selle, et al.
Atherosclerosis|September 4, 2018
Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosisRaghav Oberoi, Ann-Kathrin Vlacil, Jutta Schuett, et al.
Atherosclerosis|October 31, 2006
Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidationMaren Luchtefeld, Nele Bandlow, Uwe J F Tietge, et al.
Hypertension (Dallas, Tex. : 1979)|October 7, 2009
Hepatocyte gp130 deficiency reduces vascular remodeling after carotid artery ligationGustavo Salguero, Harald Schuett, Joanna Jagielska, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 23, 2013
Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injuryKarsten Grote, Kristina Sonnenschein, Piyushkumar R Kapopara, et al.
Plos One|May 17, 2011
Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathwaysMaren Luchtefeld, Christoph Preuss, Frank Rühle, et al.
Plos One|September 15, 2015
Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery DiseaseRaghav Oberoi, Eskindir P Bogalle, Lukas A Matthes, et al.
Pageof 6